These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care. De Jong HJI; Voorham J; Scadding GK; Bachert C; Canonica GW; Smith P; Wahn U; Ryan D; Castillo JA; Carter VA; Murray RB; Price DB World Allergy Organ J; 2020 Dec; 13(12):100490. PubMed ID: 33376573 [TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy and safety of MP-AzeFlu for the treatment of allergic rhinitis: a meta-analysis. Zhong Z; Xun Y; Shi X; Guan B; Wang M Eur Arch Otorhinolaryngol; 2022 May; 279(5):2457-2464. PubMed ID: 34415405 [TBL] [Abstract][Full Text] [Related]
24. A multicenter, prospective, noninterventional study in a Norwegian cohort of patients with moderate-to-severe allergic rhinitis treated with MP-AzeFlu. Dollner R; Lorentz Larsen P; Dheyauldeen S; Steinsvåg S Allergy Rhinol (Providence); 2017 Oct; 8(3):148-156. PubMed ID: 29070272 [TBL] [Abstract][Full Text] [Related]
25. An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu Marth K; Renner A; Langmayr G; Pohl W; Nguyen DT; Kuhl HC Drugs Real World Outcomes; 2024 Jun; 11(2):231-240. PubMed ID: 38351402 [TBL] [Abstract][Full Text] [Related]
26. MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis. van Weissenbruch R; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; Kuhl HC; Pohl W; Scadding GK; Price D; Mullol J J Asthma Allergy; 2020; 13():633-645. PubMed ID: 33293835 [TBL] [Abstract][Full Text] [Related]
27. Allergic rhinitis and asthma symptoms in a real-life study of MP-AzeFlu to treat multimorbid allergic rhinitis and asthma. Price D; Klimek L; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J Clin Mol Allergy; 2020; 18():15. PubMed ID: 32782442 [TBL] [Abstract][Full Text] [Related]
28. Deposition characteristics of a novel intranasal formulation of azelastine hydrochloride plus fluticasone propionate in an anatomic model of the human nasal cavity. Meltzer EO; Bachert C; Mayer MJ; Kopietz F; Koltun A; Maus J; D'Addio AD Allergy Asthma Proc; 2020 Jul; 41(4):265-270. PubMed ID: 32393418 [No Abstract] [Full Text] [Related]
29. Bitter taste receptor agonists alter mitochondrial function and induce autophagy in airway smooth muscle cells. Pan S; Sharma P; Shah SD; Deshpande DA Am J Physiol Lung Cell Mol Physiol; 2017 Jul; 313(1):L154-L165. PubMed ID: 28450286 [TBL] [Abstract][Full Text] [Related]
30. Genetic deletion of the Tas2r143/Tas2r135/Tas2r126 cluster reveals that TAS2Rs may not mediate bitter tastant-induced bronchodilation. Lu P; ElMallah MK; Liu Z; Wu C; Chen J; Lifshitz LM; ZhuGe R J Cell Physiol; 2021 Sep; 236(9):6407-6423. PubMed ID: 33559206 [TBL] [Abstract][Full Text] [Related]
31. The bitter taste receptor (TAS2R) agonist denatonium promotes a strong relaxation of rat corpus cavernosum. Navarro-Dorado J; Climent B; López-Oliva ME; Pilar Martínez M; Hernández-Martín M; Agis-Torres Á; Recio P; Victoria Barahona M; Benedito S; Fernandes VS; Hernández M Biochem Pharmacol; 2023 Sep; 215():115754. PubMed ID: 37597814 [TBL] [Abstract][Full Text] [Related]
32. Pleiotropic Effects of Bitter Taste Receptors on [Ca2+]i Mobilization, Hyperpolarization, and Relaxation of Human Airway Smooth Muscle Cells. Camoretti-Mercado B; Pauer SH; Yong HM; Smith DC; Deshpande DA; An SS; Liggett SB PLoS One; 2015; 10(6):e0131582. PubMed ID: 26121686 [TBL] [Abstract][Full Text] [Related]
33. Intranasal spray medications for maintenance therapy of allergic rhinitis. Berger WE; Meltzer EO Am J Rhinol Allergy; 2015; 29(4):273-82. PubMed ID: 26132312 [TBL] [Abstract][Full Text] [Related]
34. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults. Shah SR; Nayak A; Ratner P; Roland P; Michael Wall G Clin Ther; 2009 Jan; 31(1):99-107. PubMed ID: 19243710 [TBL] [Abstract][Full Text] [Related]
35. Coupling of Airway Smooth Muscle Bitter Taste Receptors to Intracellular Signaling and Relaxation Is via G Kim D; Woo JA; Geffken E; An SS; Liggett SB Am J Respir Cell Mol Biol; 2017 Jun; 56(6):762-771. PubMed ID: 28145731 [TBL] [Abstract][Full Text] [Related]
36. Bitter taste receptor function in asthmatic and nonasthmatic human airway smooth muscle cells. Robinett KS; Koziol-White CJ; Akoluk A; An SS; Panettieri RA; Liggett SB Am J Respir Cell Mol Biol; 2014 Apr; 50(4):678-83. PubMed ID: 24219573 [TBL] [Abstract][Full Text] [Related]
37. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis. Carr WW; Ratner P; Munzel U; Murray R; Price D; Canonica GW; Mullol J; Virchow JC; Lieberman P; Meltzer E; Bachert C Allergy Asthma Proc; 2012; 33(6):450-8. PubMed ID: 23127291 [TBL] [Abstract][Full Text] [Related]
38. Effect of Specific Immunoglobulin E Response and Comorbidities on Effectiveness of MP-AzeFlu in a Real-Life Study. Klimek L; Price D; Gálffy G; Emmeluth M; Koltun A; Kopietz F; Nguyen DT; van Weissenbruch R; Pohl W; Kuhl HC; Scadding G; Mullol J Int Arch Allergy Immunol; 2020; 181(10):754-764. PubMed ID: 32829329 [TBL] [Abstract][Full Text] [Related]